MedDevNews, Q1 2024

The first quarter of 2024 showed continued softness across the MedTech M&A and private financing market, with a decline across all categories compared to 2023. However, the industry is gearing up for an increase in activity in late 2024 and 2025, especially with technology-driven, highly differentiated OEMs and PE-backed CMOs that emerged from the post-pandemic slump as stronger organizations. Read the full report here.

For more insights on sector trends or to discuss your strategic priorities, contact one of our healthcare experts.